S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

SLXNW Silexion Therapeutics Corporation

0.056

0.00 (0.00%)

Pre Market

Last Updated: 18:00:00

Delayed by 15 minutes

Form 424B4 - Prospectus [Rule 424(b)(4)]

Article too big to display. Click here to view on the SEC website

Silexion Therapeutics (NASDAQ:SLXNW)
Historical Stock Chart
From Mar 2025 to Apr 2025

Click Here for more Silexion Therapeutics Charts.

Silexion Therapeutics (NASDAQ:SLXNW)
Historical Stock Chart
From Apr 2024 to Apr 2025

Click Here for more Silexion Therapeutics Charts.

Silexion Therapeutics Corporation News

Form POS AM - Post-Effective amendments for registration statement
Wednesday 30 April 2025 (13 hours ago) • Edgar (US Regulatory)

Form AW - Amendment Withdrawal Request
Wednesday 30 April 2025 (14 hours ago) • Edgar (US Regulatory)

Form AW - Amendment Withdrawal Request
Wednesday 30 April 2025 (14 hours ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Wednesday 30 April 2025 (18 hours ago) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Monday 28 April 2025 (2 days ago) • Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement
Thursday 24 April 2025 (7 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 23 April 2025 (7 days ago) • Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement
Friday 11 April 2025 (3 weeks ago) • Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement
Friday 11 April 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Wednesday 2 April 2025 (4 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 28 March 2025 (1 month ago) • Edgar (US Regulatory)

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Friday 28 March 2025 (1 month ago) • Edgar (US Regulatory)

More Silexion Therapeutics Corporation News Articles

Mapfre Sociedad Anonima

SPDR S&P US Communicatio...

WisdomTree Copper 3x Dai...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions